Delivery Order SPE2DE24DA011-SPE2D624F2EAB

Award Date 9/10/24
Potential Completion Date 9/19/24
Potential Value $2.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, from the U.S. Department of Veterans Affairs (VA). The contract, identified as SPE2DE24D0020, is an Indefinite Delivery Contract (IDC) valued at $471,048,172.66, with a period of performance from June 11, 2024, to September 1, 2029. This single-award IDC allows VA medical centers nationwide to acquire Arthrex's innovative joint replacement and implant technologies on an...
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, awarded by the Department of Veterans Affairs (VA), is an Indefinite Delivery Contract (IDC) valued at $471,048,172.66 with a period of performance from June 11, 2024, to September 1, 2029. The contract allows VA medical centers nationwide to acquire Arthrex's innovative joint replacement and implant technologies on an as-needed basis through task orders....
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, provides the U.S. Department of Veterans Affairs (VA) with a wide range of specialized surgical implants, instruments, and biologics. The contract, a single-award Indefinite Delivery Contract (IDC) valued at $471,048,172.66, allows VA medical centers nationwide to acquire Arthrex's innovative joint replacement and implant technologies on an as-needed basis through task orders....
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, provides the Department of Veterans Affairs (VA) with a wide range of surgical devices, implants, instruments, and biologics. The contract, identified as SPE2DE24D0020, is an Indefinite Delivery Contract (IDC) valued at $471,048,172.66 with a period of performance from June 11, 2024, to September 1, 2029. Through this IDC, VA medical centers nationwide can efficiently access...
This is a federal contract award from the Department of Veterans Affairs (VA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The award, identified as SPE2DE24D0020, is a single-award Indefinite Delivery Contract (IDC) valued at $471,048,172.66 with a period of performance from June 11, 2024, to September 1, 2029. Under this IDC, the VA can acquire a variety of Arthrex's innovative joint replacement and implant technologies through task orders,...
This is a federal contract award from the Department of Veterans Affairs (VA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, identified as SPE2DE24D0020, is an Indefinite Delivery Contract (IDC) valued at $471,048,172.66 with a performance period from June 11, 2024, to September 1, 2029. Under this IDC, the VA can acquire a variety of Arthrex's innovative joint replacement and implant technologies, including surgical implants,...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, identified as SPE2DE24D0020, is an Indefinite Delivery Contract (IDC) valued at $471,048,172.66 and runs from June 11, 2024, to September 1, 2029. Under this contract, Arthrex will provide a wide range of orthopedic products to VA medical centers nationwide, including surgical implants,...
This is a federal contract award from the Department of Veterans Affairs (VA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The award, identified as SPE2DE24D0020, is an Indefinite Delivery Contract (IDC) valued at $471,048,172.66 with a period of performance from June 11, 2024, to September 1, 2029. This single-award IDC allows VA medical centers nationwide to acquire Arthrex's innovative joint replacement and implant technologies on an as-needed...
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, by the Department of Veterans Affairs (VA). The contract, identified as SPE2DE24D0020, is an Indefinite Delivery Contract (IDC) valued at $471,048,172.66 with a period of performance from June 11, 2024, to September 1, 2029. Through this IDC, VA medical centers nationwide can acquire a variety of Arthrex's innovative joint replacement and implant technologies on an...
This is a federal contract award from the Department of Veterans Affairs (VA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, identified as SPE2DE24D0020, is an Indefinite Delivery Contract (IDC) valued at $471,048,172.66 with a period of performance from June 11, 2024, to September 1, 2029. Under this IDC, the VA can acquire a variety of Arthrex's innovative orthopedic products, such as joint replacement technologies, surgical implants,...
  • SPE2DE24DA011
    Indefinite Delivery Contract
  • SPE2DE24DA011-SPE2D624F2EAB
    Delivery Order

The federal contract award was issued by the Department of Veterans Affairs (VA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, identified as SPE2DE24D0020, is an Indefinite Delivery Contract (IDC) valued at $471,048,172.66 with a period of performance from June 11, 2024, to September 1, 2029. This single-award IDC allows VA medical centers nationwide to acquire Arthrex's innovative joint replacement and implant technologies on an as-needed basis through task orders. The contract does not have a set-aside designation, indicating Arthrex's competitive position in the open market for federal contracts. Under this IDC, Arthrex has received multiple delivery orders totaling over $550,000 for a variety of orthopedic products, including surgical implants, arthroscopic instruments, and biologics to support healthcare providers in treating patients more effectively.

Generated 12/10/24, 2:33 PM